Michael O’Rourke is Chief Executive Officer and a Board Director of Re-Vana Therapeutics. He is also specialised ophthalmic pharma consultant with more than three decades’ expertise in pharmaceutical, drug delivery and medical device strategies. In 2009 he founded Scotia Vision Consultants advising ophthalmic companies on commercialisation and product development with a focus on anterior and posterior ocular drug delivery. Previously he’s worked for 3M, Pfizer, Alza, Chiron Vision, Bausch + Lomb and GrayBug.

More contributions